Predictors of 18F-fluorodeoxyglucose (F) positron-emission tomography (PET)-driven disease detection in patients (pts) with HER2[+] early breast cancer (EBC). A substudy of the PHERGain trial
No Thumbnail Available
Identifiers
Date
2020-05-01
Authors
Llombart Cussac, A.
Prat, A.
Perez-Garcia, J. M.
Mateos, J.
Pascual, T.
Escriva-De-Romani, S.
Stradella, A.
Ruiz-Borrego, M.
Bermejo De Las Heras, B.
Keyaerts, M.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Metrics
Export
